Name: SourceBio International - Q&A with Executive Chairman Jay Lecoque
Uploaded: 2022-06-15T06:14:20.192503+00:00
Duration: 893 s
Channel: Vox Markets

Vox Markets

After today's positive trading update, Executive Chairman Jay Lecoque of SourceBio International takes me through the:

Tremendous underlying demand being experienced in the Cellular Pathology operation (SBI)  Start to 03:24.10
Integration & synergies from the LDPath acquisition (SBI) 03:24.10
Planned capacity expansion (SBI) 05:16.18
Introduction of AI (SBI) 06:06.10 
Genomics division & opportunity in Precision Medicine. (SBI) 08:09.06
Stability Storage (SBI) 10:19.03
Repurposing Covid testing resource & equipment (SBI) 11:22.04
Possible future M&A (SBI) 12:30.09
SBI’s overall outlook for (SBI) 2022. 13:02.15

After today's positive trading update, Executive Chairman Jay Lecoque of SourceBio International takes me through the:Tremendous underlying demand being experienced in the Cellular Pathology operation (SBI) Start to 03:24.10 Integration &amp; synergies from the LDPath acquisition (SBI) 03:24.10 Planned capacity expansion (SBI) 05:16.18 Introduction of AI (SBI) 06:06.10 Genomics division &amp; opportunity in Precision Medicine. (SBI) 08:09.06 Stability Storage (SBI) 10:19.03 Repurposing Covid testing resource &amp; equipment (SBI) 11:22.04 Possible future M&amp;A (SBI) 12:30.09 SBI’s overall outlook for (SBI) 2022. 13:02.15

Tremendous underlying demand being experienced in the Cellular Pathology operation (SBI)

Integration & synergies from the LDPath acquisition (SBI)

Planned capacity expansion (SBI)

Introduction of AI (SBI)

Genomics division & opportunity in Precision Medicine. (SBI)

Stability Storage (SBI)

Repurposing Covid testing resource & equipment (SBI)

Possible future M&A (SBI)

SBI’s overall outlook for (SBI)

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/003/935/003935/video_V9tto35.mp4